Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2005
08/04/2005US20050171173 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171104 Novel thyroid receptor ligands
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171098 MCH antagonists and their use in the treatment of obesity
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005DE102004002044A1 Herstellverfahren Manufacturing process
08/04/2005CA2554138A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/04/2005CA2553729A1 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
08/04/2005CA2553266A1 Substituted quinolines and their use as mycobacterial inhibitors
08/04/2005CA2552784A1 Beta-2-agonists, and their use as medicaments
08/04/2005CA2552419A1 Azadecalin glucocorticoid receptor modulators
08/03/2005EP1559715A1 N-[2-chloro-4-(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1558608A1 Oxindole substituted piperazine derivatives
08/03/2005EP1558598A1 Triazole compounds for the treatment of dysmenorrhoea
08/03/2005EP1558585A1 Neurologically-active compounds
08/03/2005EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558248A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
08/03/2005EP1558247A1 Benzimidazole derivatives
08/03/2005EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649866A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649850A Cyclic compound, process for producing the same, and pest control agent
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649594A Process for the preparation of benazepril hydrochloride
08/03/2005CN1649587A Use of epothilones in the treatment of brain diseases associated with proliferative processes
08/03/2005CN1649498A 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213037C Halogenated pyrimidine and its application for reducing parasite
08/03/2005CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/03/2005CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924298 Useful as insecticides and acaricides
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068466A1 Compounds useful in therapy
07/28/2005WO2005068457A1 Cataltytic asymmetric hetero diels-alder reaction of a heteroaromatic c-nitroso dienophile: a novel method for synthesis of chiral non-racemic amino alcohols
07/28/2005WO2005068456A1 Production method
07/28/2005WO2005068448A1 Sulfonamides antagonising n-type calcium channels
07/28/2005WO2005068442A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors
07/28/2005WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
07/28/2005WO2005068433A1 Benzimidazole derivatives
07/28/2005WO2005068424A1 Indolinone derivatives as receptor tyrosine kinase ihibitors
07/28/2005WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
07/28/2005WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/28/2005WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2005042517A3 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
07/28/2005WO2005037239A3 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt
07/28/2005WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
07/28/2005WO2004108719A9 2-[2-(4-morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
07/28/2005WO2004098498A3 Indole acetic acid derivatives and their use as pharmaceutical agents
07/28/2005WO2004060306A3 Anti-inflammatory medicaments
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165067 Aryl sulfonamides
07/28/2005US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
07/28/2005US20050165055 Novel substituted indoles
07/28/2005US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/28/2005US20050165020 5-(2,6-Difluorobenzyloxymethyl)-5-methyl-3-(3-propylisoxazol-5-yl)-4,5-dihydroisoxazole, used as preemergence or postemergence plant growth regulators
07/28/2005US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
07/28/2005US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer
07/28/2005US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/28/2005US20050165015 Vanilloid receptor ligands and their use in treatments
07/28/2005US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis
07/28/2005US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
07/28/2005US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof
07/28/2005US20050164973 E.g., 3-[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay
07/28/2005US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005US20050164868 Non-heating clay composites for building materials
07/28/2005US20050164120 High photosensitivity, visible laser recording materials; comprised of novel squarylium compound metal complexes, free radical generators and monomers
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 647